AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $929,681 | +124.0% | 62,186 | +23.3% | 0.00% | – |
| Q3 2022 | $415,000 | +21.3% | 50,441 | -3.3% | 0.00% | – |
| Q2 2022 | $342,000 | +14.0% | 52,146 | -2.6% | 0.00% | – |
| Q1 2022 | $300,000 | +12.4% | 53,547 | -6.0% | 0.00% | – |
| Q4 2021 | $267,000 | -27.2% | 56,944 | -3.8% | 0.00% | – |
| Q3 2021 | $367,000 | -0.5% | 59,181 | +5.7% | 0.00% | – |
| Q2 2021 | $369,000 | -78.0% | 55,993 | -75.5% | 0.00% | – |
| Q1 2021 | $1,675,000 | +19.6% | 228,786 | -5.8% | 0.00% | – |
| Q4 2020 | $1,401,000 | +3.3% | 242,839 | +6.3% | 0.00% | – |
| Q3 2020 | $1,356,000 | +63.4% | 228,369 | +41.7% | 0.00% | – |
| Q2 2020 | $830,000 | +822.2% | 161,217 | +548.3% | 0.00% | – |
| Q1 2020 | $90,000 | – | 24,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
| Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
| NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
| Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
| Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
| EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
| EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
| J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |